spacer
home > ebr > spring 2002 > a record-breaking us$27 billion of biotech deals supports strong pharma m&a activity in 2001
PUBLICATIONS
European Biopharmaceutical Review

A Record-Breaking US$27 Billion of Biotech Deals Supports Strong Pharma M&A Activity in 2001

The value of pharmaceutical mergers and acquisitions (M&A) in 2001 almost doubled to US$61 billion from US$34 billion in 2000 (excluding the US$76 billion formation that year of GlaxoSmithKline), bucking the significant downward trend witnessed in most other sectors. The number of deals remained stable at 334 in 2001, compared with 341 in 2000. In a period where most industries have experienced at least a 25 per cent downturn in M&A activity, the pharmaceutical sector has maintained its deal-making momentum. The aggregate value of deals is down because 2001 witnessed no mega-mergers to rival the prior year combination of Glaxo Wellcome and SmithKline Beecham. But with Amgen's US$17 billion bid for Immunex, plus a further US$10 billion of biotech deals in 2001, the foundations are being laid for a Big Biotech sector that will increasingly compete with Big Pharma.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Neal Ransome, Partner at PricewaterhouseCoopers Corporate Finance

Neal Ransome is European leader of PricewaterhouseCoopers' Pharmaceuticals and Healthcare Corporate Finance team. He has over 10 years' experience of corporate finance transactions, and has been focusing on the pharma and health care sectors since 1997. Neal's clients in the sector have included large pharmacos such as GlaxoSmithKline and Aventis, emerging companies such as Powderject and a wide range of smaller clients in the health care and biotech sectors.
Neal has also acted for a large number of private equity clients in the sector, including 3i, Warburg Pincus and Mercury. The European team which he leads comprises approximately 20 professional staff, located in all key financial centres, and combines corporate finance experts with recruits from the industry.

spacer
Neal Ransome
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

AstroNova introduces its range of grass paper labels derived from grass for high quality organic products

Dietzenbach, 29 April 2019, AstroNova GmbH, European headquarters of AstroNova Inc. (RI, USA), responsible for Sales and Customer Service in Europe, the Middle East and Africa (EMEA), is extending its Product Identification range with new approved labelling for direct foodstuff contact.
More info >>

White Papers

Competitive Drive: The Challenges of a Globalised Packaging Industry

Aesica Pharmaceuticals

Packaging is becoming an increasingly competitive and lucrative industry globally. Jeremy Drummond PhD of Aesica Formulated Products looks at the challenges and opportunities this presents.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement